Scan to Download
One powerful score. Smarter investment decisions.
AN2 Therapeutics Inc
ANTX1.120USD
-0.020-1.75%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
30.66MMarket Cap
LossP/E TTM
AN2 Therapeutics Inc
1.120
-0.020-1.75%
You can access the annual and quarterly cash flow statements of AN2 Therapeutics Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
46.91%-6.38M
47.17%-7.60M
39.61%-10.62M
69.11%-5.27M
-1.75%-12.01M
-12.16%-14.38M
-51.72%-17.59M
-123.46%-17.07M
-24.38%-11.80M
-33.65%-12.82M
-72.00%-11.60M
---7.64M
---9.49M
---9.60M
---6.74M
Net income from continuing operations
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
-42.70%-16.90M
-47.34%-16.71M
-56.17%-15.80M
-100.17%-15.32M
---11.84M
---11.34M
---10.12M
---7.66M
Other non-cash items
71.14%-211.00K
66.40%-299.00K
59.40%-443.00K
56.58%-567.00K
-14.22%-731.00K
-102.27%-890.00K
-162.26%-1.09M
-267.89%-1.31M
-184.44%-640.00K
-730.19%-440.00K
-2289.47%-416.00K
---355.00K
---225.00K
---53.00K
--19.00K
Change in working capital
654.06%2.39M
-113.23%-2.84M
30.44%-1.58M
194.53%1.04M
-112.76%-431.00K
-190.05%-1.33M
-209.40%-2.27M
-135.50%-1.10M
297.88%3.38M
322.44%1.48M
366.29%2.08M
--3.09M
--849.00K
---664.00K
--445.00K
-Change in prepaid expenses
880.43%2.51M
-127.04%-1.80M
-41.84%645.00K
231.24%815.00K
-1633.33%-322.00K
31.93%-795.00K
49.46%1.11M
-159.03%-621.00K
-96.69%21.00K
43.82%-1.17M
231.10%742.00K
--1.05M
--634.00K
---2.08M
---566.00K
-Change in other current assets
----
----
----
----
----
----
----
----
----
----
----
---720.00K
----
----
----
-Change in other current liabilities
-174.48%-534.00K
45.61%348.00K
-21.97%-422.00K
-57.65%-484.00K
-26.31%717.00K
--239.00K
---346.00K
---307.00K
--973.00K
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
46.91%-6.38M
47.17%-7.60M
39.61%-10.62M
69.11%-5.27M
-1.75%-12.01M
-12.16%-14.38M
-51.72%-17.59M
-123.46%-17.07M
-24.38%-11.80M
-33.65%-12.82M
-72.00%-11.60M
---7.64M
---9.49M
---9.60M
---6.74M
Investing cash flow
Net cash flow from investment products
-67.36%6.11M
-64.56%5.83M
-65.03%9.19M
-1738.10%-6.88M
129.97%18.72M
108.96%16.46M
141.48%26.29M
-93.06%420.00K
-2595.81%-62.46M
119.95%7.88M
-22.11%10.89M
--6.05M
---2.32M
---39.49M
--13.98M
Cash from non-current investing activities
Net cash flow from investing activities
-67.36%6.11M
-64.56%5.83M
-65.03%9.19M
-1738.10%-6.88M
129.97%18.72M
108.96%16.46M
141.48%26.29M
-93.06%420.00K
-2595.81%-62.46M
119.95%7.88M
-22.11%10.89M
--6.05M
---2.32M
---39.49M
--13.98M
Financing cash flow
Cash flow from continuous financing activities
108.70%48.00K
--0.00
-81.38%65.00K
100.00%0.00
-99.97%23.00K
-100.00%0.00
75.38%349.00K
---321.00K
660760.00%66.07M
165.39%19.05M
-99.69%199.00K
--0.00
---10.00K
--7.18M
--63.19M
Net cash flow from common stock issuance/repurchase
108.70%48.00K
--0.00
-69.35%38.00K
--0.00
-99.97%23.00K
-100.00%0.00
-37.69%124.00K
--0.00
659770.00%65.97M
165.39%19.05M
-99.69%199.00K
--0.00
---10.00K
--7.18M
--63.20M
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
Proceeds from stock option exercised by employees
--0.00
--0.00
-88.00%27.00K
--0.00
-100.00%0.00
--0.00
--225.00K
--0.00
--99.00K
--0.00
100.00%0.00
--0.00
--0.00
--0.00
---11.00K
Net cash flow from other financing activities
----
----
----
----
----
----
----
---321.00K
----
----
----
----
----
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
108.70%48.00K
--0.00
-81.38%65.00K
100.00%0.00
-99.97%23.00K
-100.00%0.00
75.38%349.00K
---321.00K
660760.00%66.07M
165.39%19.05M
-99.69%199.00K
--0.00
---10.00K
--7.18M
--63.19M
Net cash flow
Beginning cash balance
-31.94%18.22M
-19.07%19.98M
36.45%21.35M
2.72%33.50M
-34.41%26.77M
-7.55%24.69M
-42.51%15.65M
13.24%32.62M
0.48%40.81M
-67.63%26.71M
125.01%27.22M
--28.80M
--40.62M
--82.52M
--12.10M
Current period cash flow changes
-103.22%-217.00K
-185.02%-1.76M
-115.10%-1.37M
28.38%-12.15M
182.17%6.74M
-85.28%2.08M
1873.73%9.05M
-971.95%-16.97M
30.62%-8.20M
133.66%14.10M
-100.72%-510.00K
---1.58M
---11.81M
---41.90M
--70.42M
Ending cash balance
-46.27%18.00M
-31.94%18.22M
-19.07%19.98M
36.45%21.35M
2.72%33.50M
-34.41%26.77M
-7.55%24.69M
-42.51%15.65M
13.24%32.62M
0.48%40.81M
-67.63%26.71M
--27.22M
--28.80M
--40.62M
--82.52M
Free cash flow
46.91%-6.38M
47.17%-7.60M
39.61%-10.62M
69.11%-5.27M
-1.75%-12.01M
-12.16%-14.38M
-51.72%-17.59M
-123.46%-17.07M
-24.38%-11.80M
-33.65%-12.82M
-72.00%-11.60M
---7.64M
---9.49M
---9.60M
---6.74M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
FAQs
What is the cash flow statement?
This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
